Health Catalyst, Inc. Income Statement
HCAT|7 years of annual SEC 10-K data (FY2019-FY2025)
Line items include revenue, cost of goods sold, gross profit, operating expenses, interest, taxes, and net income with per-share data across 7 fiscal years. All figures from audited SEC 10-K filings.
Health Catalyst, Inc. reported $296M in revenue and $118M in net loss for FY2025. Revenue has grown at a 26.3% compound annual rate over the past 6 years.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score 1.03 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Revenue | $295.9M | $276.2M | $241.9M | $188.8M | $154.9M | $112.6M | $73.1M |
| SG&A Expense | $76.6M | $61.7M | $85.9M | $59.2M | $31.7M | $22.7M | $14.7M |
| R&D Expense | $72.6M | $75.7M | $62.7M | $53.5M | $46.3M | $38.6M | $28.5M |
| Operating Income | -$126.9M | -$140.0M | -$143.7M | -$96.1M | -$54.9M | -$60.1M | -$45.5M |
| Income Tax | $356.0K | -$4.3M | -$6.9M | -$1.2M | $142.0K | -$135.0K | $26.0K |
| Net Income | -$118.1M | -$137.4M | -$153.2M | -$115.0M | -$60.1M | -$62.0M | -$47.0M |
| EPS (Basic) | -$2.09 | -$2.56 | -$3.23 | -$2.91 | -$12.86 | - | - |
| EPS (Diluted) | -$2.09 | -$2.63 | -$3.23 | -$2.91 | -$12.86 | -$23.76 | -$12.13 |
| Shares Outstanding | 64.0M | 58.3M | 55.3M | 52.6M | 43.4M | 36.7M | 4.8M |
| Operating Margin | -42.9% | -50.7% | -59.4% | -50.9% | -35.4% | -53.4% | -62.3% |
| Profit Margin | -39.9% | -49.7% | -63.3% | -60.9% | -38.8% | -55.1% | -64.4% |